Skip to main content
Signal8

Rothman Paul

SEC insider (Form 3/4/5 filer). CIK 0001601332. Director at Merck & Co., Inc. (MRK) and 1 other issuer. 6 reported Form 4/5 transactions since Sep 2024; latest on May 29, 2026. Located in RAHWAY, NJ.

Companies Rothman Paul has filed insider reports for

  • Merck & Co., Inc. (MRK): Director
  • LABCORP HOLDINGS INC. (LH): Director
Rothman Paul profile photo

Rothman Paul

CIK: 0001601332

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)2 (33.3%)

Derivative conversions

Awards (A)4 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Merck & Co., Inc. logo
MRK

Merck & Co., Inc.

Director
LABCORP HOLDINGS INC. logo
LH

LABCORP HOLDINGS INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

  • Merck & Co., Inc. logo
    MRK

    Merck & Co., Inc.

    May 29, 2026
    Award

    Phantom Stock

    Direct
    1.9K shares at avg. $118.72-
  • LABCORP HOLDINGS INC. logo
    LH

    LABCORP HOLDINGS INC.

    Feb 11, 2026
    Exercise
    Direct
    897 shares-
  • LABCORP HOLDINGS INC. logo
    LH

    LABCORP HOLDINGS INC.

    Feb 10, 2026
    Award

    Restricted Stock Unit

    Direct
    733 shares-
  • Merck & Co., Inc. logo
    MRK

    Merck & Co., Inc.

    May 30, 2025
    Award

    Phantom Stock

    Direct
    2.9K shares at avg. $76.84-
  • LABCORP HOLDINGS INC. logo
    LH

    LABCORP HOLDINGS INC.

    Feb 11, 2025
    Award

    Restricted Stock Unit

    Direct
    897 shares-
  • LABCORP HOLDINGS INC. logo
    LH

    LABCORP HOLDINGS INC.

    Feb 6, 2025
    Exercise
    Direct
    944 shares-

1-6 of 6